10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium

C60H55N15O4Ru — CID 59008874

IUPAC10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium
SMILESCc1ccnc(-c2cc(C)ccn2)c1.Cn1cc(NC(=O)c2cc(NC(=O)c3nccn3C)cn2C)cc1C(=O)NCOc1cc2cccnc2c2ncccc12.[Ru].c1cnc2c(c1)c1c(c3cccnc32)NC2CCCCC2=N1
InChIInChI=1S/C30H27N9O4.C18H16N4.C12H12N2.Ru/c1-37-11-10-33-27(37)30(42)36-20-14-23(39(3)16-20)29(41)35-19-13-22(38(2)15-19)28(40)34-17-43-24-12-18-6-4-8-31-25(18)26-21(24)7-5-9-32-26;1-2-8-14-13(7-1)21-17-11-5-3-9-19-15(11)16-12(18(17)22-14)6-4-10-20-16;1-9-3-5-13-11(7-9)12-8-10(2)4-6-14-12;/h4-16H,17H2,1-3H3,(H,34,40)(H,35,41)(H,36,42);3-6,9-10,13,21H,1-2,7-8H2;3-8H,1-2H3;
InChIKeyBXJOPQNRWIJBIN-UHFFFAOYSA-N
MW1151.27 g/mol
LogP10.45
Rot. Bonds9

About 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium

10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium (PubChem CID 59008874) has the molecular formula C60H55N15O4Ru and a molecular weight of 1151.27 g/mol. Its IUPAC name is 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium.

Molecular Properties

Compound Name10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium
PubChem CID59008874
Molecular FormulaC60H55N15O4Ru
Molecular Weight1151.27 g/mol
Exact Mass1151.36
IUPAC Name10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium
SMILESCc1ccnc(-c2cc(C)ccn2)c1.Cn1cc(NC(=O)c2cc(NC(=O)c3nccn3C)cn2C)cc1C(=O)NCOc1cc2cccnc2c2ncccc12.[Ru].c1cnc2c(c1)c1c(c3cccnc32)NC2CCCCC2=N1
InChIInChI=1S/C30H27N9O4.C18H16N4.C12H12N2.Ru/c1-37-11-10-33-27(37)30(42)36-20-14-23(39(3)16-20)29(41)35-19-13-22(38(2)15-19)28(40)34-17-43-24-12-18-6-4-8-31-25(18)26-21(24)7-5-9-32-26;1-2-8-14-13(7-1)21-17-11-5-3-9-19-15(11)16-12(18(17)22-14)6-4-10-20-16;1-9-3-5-13-11(7-9)12-8-10(2)4-6-14-12;/h4-16H,17H2,1-3H3,(H,34,40)(H,35,41)(H,36,42);3-6,9-10,13,21H,1-2,7-8H2;3-8H,1-2H3;
InChIKeyBXJOPQNRWIJBIN-UHFFFAOYSA-N
XLogP10.45
TPSA225.94 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds9
Heavy Atoms80
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001151.27
LogP ≤ 510.45
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium?
The IUPAC name of 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium (CID 59008874) is 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium.
What is the SMILES notation for 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium?
The canonical SMILES for 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium is Cc1ccnc(-c2cc(C)ccn2)c1.Cn1cc(NC(=O)c2cc(NC(=O)c3nccn3C)cn2C)cc1C(=O)NCOc1cc2cccnc2c2ncccc12.[Ru].c1cnc2c(c1)c1c(c3cccnc32)NC2CCCCC2=N1.
What is the InChIKey of 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium?
The InChIKey is BXJOPQNRWIJBIN-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H27N9O4.C18H16N4.C12H12N2.Ru/c1-37-11-10-33-27(37)30(42)36-20-14-23(39(3)16-20)29(41)35-19-13-22(38(2)15-19)28(40)34-17-43-24-12-18-6-4-8-31-25(18)26-21(24)7-5-9-32-26;1-2-8-14-13(7-1)21-17-11-5-3-9-19-15(11)16-12(18(17)22-14)6-4-10-20-16;1-9-3-5-13-11(7-9)12-8-10(2)4-6-14-12;/h4-16H,17H2,1-3H3,(H,34,40)(H,35,41)(H,36,42);3-6,9-10,13,21H,1-2,7-8H2;3-8H,1-2H3;.
What are the key properties of 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium?
10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium has a molecular weight of 1151.27 g/mol, XLogP of 10.45, 9 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 10,11,12,13,13a,14-hexahydroquinoxalino[2,3-f][1,10]phenanthroline;1-methyl-N-[1-methyl-5-[[1-methyl-5-(1,10-phenanthrolin-5-yloxymethylcarbamoyl)pyrrol-3-yl]carbamoyl]pyrrol-3-yl]imidazole-2-carboxamide;4-methyl-2-(4-methyl-2-pyridinyl)pyridine;ruthenium is sourced from PubChem (CID 59008874), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).